These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9636587)

  • 1. Metabolic findings after liver transplantation within a randomised trial with or without steroids.
    Tisone G; Angelico M; Vennarecci G; Palmieri G; Buonomo O; Negrini S; Casciani CU
    Transplant Proc; 1998 Jun; 30(4):1447-8. PubMed ID: 9636587
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
    Lladó L; Figueras J; Ramos E; Baliellas C; Torras J; Rafecas A; Fabregat J; Lama C; Ibañez L; Jaurrieta E
    Transplant Proc; 2002 Aug; 34(5):1526-8. PubMed ID: 12176468
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum lipid changes in liver transplantation: effect of steroids withdrawn in a prospective randomized trial under cyclosporine A therapy.
    De Carlis L; Belli LS; Colella G; Rondinara GF; Slim AO; Alberti A; Aseni P; Sansalone CV; Pirotta V; Di Benedetto F; Forti D
    Transplant Proc; 1999; 31(1-2):391-3. PubMed ID: 10083156
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy.
    Jonas S; Guckelberger O; Tullius SG; Steinmüller T; Müller AR; Grauhan O; Langrehr JM; Bechstein WO; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2232-3. PubMed ID: 11377511
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoral-based immunosuppression in living-related donor liver transplantation.
    Liu PP; Chen CL; Chen YS; Wang CC; Chiang YC; Goto S; Cheng YF; Huang TL; Eng HL; Cheung HK; Jawan B
    Transplant Proc; 1998 Nov; 30(7):3550-1. PubMed ID: 9838554
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring of anti-rejection therapy by serum bile acids after liver transplantation.
    Klar E; Theilmann L; Hoffmann V; Hofmann W; Kraus T; Mehrabi A; Herfarth C
    Transplant Proc; 1998 Nov; 30(7):3567-9. PubMed ID: 9838562
    [No Abstract]   [Full Text] [Related]  

  • 8. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract]   [Full Text] [Related]  

  • 9. Low incidence of acute cellular rejection in liver transplantation with Neoral.
    Imventarza O; Lendoire J; Bianco G; Saúl J; Braslavsky G; Trigo P; Cueto G; Duek F; Aziz H
    Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
    Freise CE; Hebert M; Osorio RW; Nikolai B; Lake JR; Kauffman RS; Ascher NL; Roberts JP
    Transplant Proc; 1993 Apr; 25(2):1758-9. PubMed ID: 8470155
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
    Tisone G; Laria G; Orlando G; Pisani F; Palmieri GP; Bellanova G; Torri E; Buonomo O; Angelico M; Casciani CU
    Transplant Proc; 1999 Dec; 31(8):3167-8. PubMed ID: 10616427
    [No Abstract]   [Full Text] [Related]  

  • 12. Implication of Th1, Th2, and Th3 cytokines in liver graft acceptance.
    Minguela A; Torío A; Marín L; Sánchez-Bueno F; García-Alonso AM; Ontañón J; Parrilla P; Alvarez-López MR
    Transplant Proc; 1999; 31(1-2):519-20. PubMed ID: 10083217
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute cardiac ongoing rejection: comparison between different strategies.
    Forni A; Faggian G; Luciani GB; Lamascese N; Mazzucco A
    Transplant Proc; 2001 May; 33(3):2395-7. PubMed ID: 11377573
    [No Abstract]   [Full Text] [Related]  

  • 14. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract]   [Full Text] [Related]  

  • 15. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 18. Does initial graft function influence the outcome after liver transplantation?
    Mueller AR; Platz KP; Krause P; Neuhaus R; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term immunosuppression after liver transplantation: are steroids necessary?
    Padbury RT; Gunson BK; Dousset B; Hubscher SG; Mayer AD; Buckels JA; Neuberger JM; Elias E; McMaster P
    Transpl Int; 1992; 5 Suppl 1():S470-2. PubMed ID: 14621849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
    Langrehr JM; Lohmann R; Raakow R; Jonas S; Klupp J; Bechstein WO; Neuhaus R; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2290-1. PubMed ID: 11377531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.